SpringWorks Wins FDA Nod for Neurofibromatosis Drug, Tees Up Challenge to AstraZenecaBy / 12/02/2025 The approval comes days after Germany’s Merck KGaA confirmed it was in advanced talks to acquire SpringWorks.
